Comprehensive 2025 Quadrivalent Market Overview: Trends, Forecasts, and Growth Drivers

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Quadrivalent Market Through 2025?
The quadrivalent industry has experienced substantial growth in recent years. The market is projected to expand from $8.87 billion in 2024 to $9.51 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.2%. Factors contributing to the growth during the historic period include the complexity of diseases, educational programs, past health incidents, advancement in healthcare, and technological development.

What's the Projected Size of the Global Quadrivalent Market by 2029?
Anticipations are high for the quadrivalent market size to witness substantial expansion in the upcoming years. The market is predicted to surge to "$13.91 billion in 2029", experiencing a compound annual growth rate (CAGR) of 10.0%. The projected growth during this prediction period can be related to worldwide health circumstances, cutthroat competition, enlightening campaigns, modifications in regulations, and shifting disease tendencies. The major trends anticipated for this prediction period encompass disease occurrence, regulatory frameworks, healthcare facilities, consumer consciousness and education, as well as a competitive scenario.

View the full report here:
https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Top Growth Drivers in the Quadrivalent Industry: What's Accelerating the Market?
The quadrivalent market's growth is anticipated to be fueled by the increasing incidence of infectious and chronic diseases. Chronic diseases are persisting illnesses resulting from genetics and lifestyle, while any disease caused by an infectious substance such as a virus, bacteria, fungi, or protozoan is termed an infectious disease. Quadrivalent vaccines play a substantial role in reducing the severity and mortality of severe infections and diseases beyond the specific infections they aim to combat. They are employed to inhibit chronic (non-communicable) diseases when infectious agents contribute to carcinogenesis. For instance, as per the Centers for Disease Control and Prevention, a non-profit organization based in the US, in Week 37 of September 2024, 0.5% of the tested samples were positive for influenza, with influenza A constituting 91.4% and influenza B making up 8.6%. Since Week 40 starting on October 1, 2023, 8.7% of the samples tested positive for influenza, with 69.2% being influenza A and 30.8% influenza B. This data indicates an increased positivity rate and a greater percentage of influenza B cases over time. Hence, the escalating prevalence of infectious and chronic diseases is propelling the growth of the quadrivalent market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

What Trends Will Shape the Quadrivalent Market Through 2029 and Beyond?
The trend of product innovation is gaining traction in the quadrivalent market. To solidify their market position, key players in the quadrivalent market are making efforts to bring forward innovative solutions. One such example is the launch of FluMist quadrivalent (Influenza Vaccination Live, Intranasal), an FDA-approved nasal-spray flu vaccine, by AstraZeneca, a leading UK-based pharmaceutical company, in September 2022. The vaccine, which is designed for individuals aged 2 to 49, is a needle-free, live attenuated influenza vaccine (LAIV), and comes in either trivalent or quadrivalent formulations. It is currently covered under most health insurance plans, as well as the vaccines for children program.

What Are the Main Segments in the Quadrivalent Market?
The quadrivalent market covered in this report is segmented -

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray
2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies
3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Subsegments:
1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery
2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection
3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9335&type=smp

Which Top Companies are Driving Growth in the Quadrivalent Market?
Major companies operating in the quadrivalent market include AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

Which Regions Will Dominate the Quadrivalent Market Through 2029?
North America was the largest region in the quadrivalent market in 2024. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9335

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.